Alitair Pharmaceuticals Overview
- Founded
- 2010

- Status
- Private
- Employees
- 3

- Latest Deal Type
- Angel
- Latest Deal Amount
- $35K

Alitair Pharmaceuticals General Information
Description
Operator of a specialty pharmaceutical company intended to develop proprietary ion-exchange resin formulations, prescription cough medicines and a pipeline of orphan drugs. The company's patented formulation acts as a passive drug formulation system to reduce the risk of prescription drug overdose irrespective of the number of tablets or capsules ingested, enabling medical professionals to treat bronchiectasis easily and patients to get relief from respiration-related diseases quickly.
Contact Information
- 55 Madison Avenue
- Suite 400
- Morristown, NJ 07960
- United States
Alitair Pharmaceuticals Timeline
Alitair Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Angel (individual) | 11-Nov-2020 | $35K | 00.000 | Completed | Clinical Trials - General | |
4. Angel (individual) | 09-Oct-2018 | 00000 | 00.000 | Completed | Clinical Trials - General | |
3. Angel (individual) | 29-Jun-2017 | 000 | 00.00 | Completed | Clinical Trials - General | |
2. Angel (individual) | 10-Feb-2017 | $100K | $100K | Completed | Clinical Trials - General | |
1. Angel (individual) | 29-Sep-2015 | $911K | Completed | Clinical Trials - General |
Alitair Pharmaceuticals Executive Team (6)
Alitair Pharmaceuticals Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
James Hoyes | Alitair Pharmaceuticals | Chief Executive Officer & Chairman | 000 0000 |
Robert Casale | Alitair Pharmaceuticals | Board Member | 000 0000 |
Alitair Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial